Literature DB >> 9875509

Intestinal bacterial metabolism of flavonoids and its relation to some biological activities.

D H Kim1, E A Jung, I S Sohng, J A Han, T H Kim, M J Han.   

Abstract

Flavonoid glycosides were metabolized to phenolic acids via aglycones by human intestinal microflora producing alpha-rhamnosidase, exo-beta-glucosidase, endo-beta-glucosidase and/or beta-glucuronidase. Rutin, hesperidin, naringin and poncirin were transformed to their aglycones by the bacteria producing alpha-rhamnosidase and beta-glucosidase or endo-beta-glucosidase, and baicalin, puerarin and daidzin were transformed to their aglycones by the bacteria producing beta-glucuronidase, C-glycosidase and beta-glycosidase, respectively. Anti-platelet activity and cytotoxicity of the metabolites of flavonoid glycosides by human intestinal bacteria were more effective than those of the parental compounds. 3,4-Dihydroxyphenylacetic acid and 4-hydroxyl-phenylacetic acid were more effective than rutin and quercetin on anti-platelet aggregation activity. 2,4,6-Trihydroxybenzaldehyde, quercetin and ponciretin were more effective than rutin and ponciretin on the cytotoxicity for tumor cell lines. We insist that these flavonoid glycosides should be natural prodrugs.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9875509     DOI: 10.1007/bf03216747

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  53 in total

1.  Highly variable contents of phenolics in St. John's Wort products affect their transport in the human intestinal Caco-2 cell model: pharmaceutical and biopharmaceutical rationale for product standardization.

Authors:  Song Gao; Wen Jiang; Taijun Yin; Ming Hu
Journal:  J Agric Food Chem       Date:  2010-06-09       Impact factor: 5.279

2.  Simultaneous determination by UPLC-MS/MS of seven bioactive compounds in rat plasma after oral administration of Ginkgo biloba tablets: application to a pharmacokinetic study.

Authors:  Wen-ping Wang; Na Liu; Qian Kang; Pei-pei Du; Yi Lan; Bo-chen Zhao; Yan-yan Chen; Qing Zhang; Hui Li; Ye-wen Zhang; Qing Wu
Journal:  J Zhejiang Univ Sci B       Date:  2014-11       Impact factor: 3.066

3.  Intestinal bacterial metabolism and anti-complement activities of three major components of the seeds of Entada phaseoloides.

Authors:  Shihua Xing; Mengyue Wang; Ying Peng; Yuqiong Dong; Xiaobo Li
Journal:  J Nat Med       Date:  2014-11-15       Impact factor: 2.343

Review 4.  Bioavailability challenges associated with development of anti-cancer phenolics.

Authors:  Song Gao; Ming Hu
Journal:  Mini Rev Med Chem       Date:  2010-06       Impact factor: 3.862

5.  Feasibility of Genome-Wide Screening for Biosafety Assessment of Probiotics: A Case Study of Lactobacillus helveticus MTCC 5463.

Authors:  S Senan; J B Prajapati; C G Joshi
Journal:  Probiotics Antimicrob Proteins       Date:  2015-12       Impact factor: 4.609

Review 6.  Early metabolism evaluation making traditional Chinese medicine effective and safe therapeutics.

Authors:  Yong Liu; Ling Yang
Journal:  J Zhejiang Univ Sci B       Date:  2006-02       Impact factor: 3.066

Review 7.  Gut microbiota: a key player in health and disease. A review focused on obesity.

Authors:  M J Villanueva-Millán; P Pérez-Matute; J A Oteo
Journal:  J Physiol Biochem       Date:  2015-03-08       Impact factor: 4.158

8.  Cytotoxic action of methylquercetins in human lung adenocarcinoma cells.

Authors:  Katrin Sak; Helen Lust; Marju Kase; Jana Jaal
Journal:  Oncol Lett       Date:  2017-11-21       Impact factor: 2.967

9.  Human intestinal microbial metabolism of naringin.

Authors:  Wei Zou; Yulong Luo; Menghua Liu; Si Chen; Sheng Wang; Yichu Nie; Guohua Cheng; Weiwei Su; Kejian Zhang
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-06-17       Impact factor: 2.441

10.  Common gut microbial metabolites of dietary flavonoids exert potent protective activities in β-cells and skeletal muscle cells.

Authors:  Benjamin F Bitner; Jason D Ray; Kyle B Kener; Jacob A Herring; Josie A Tueller; Deborah K Johnson; Claudia M Tellez Freitas; Dane W Fausnacht; Mitchell E Allen; Alexander H Thomson; K Scott Weber; Ryan P McMillan; Matthew W Hulver; David A Brown; Jeffery S Tessem; Andrew P Neilson
Journal:  J Nutr Biochem       Date:  2018-09-15       Impact factor: 6.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.